survival in colorectal cancer
The location and amount of a protein within two separate compartments of a tumor cell may be critical markers predicting survival in colorectal cancer, according to a study at the School of Medicine.
The study revealed that high levels of the protein thymidylate synthase (TS) in the nucleus correlated with decreased patient survival time, and, further, a high ratio of TS in the nucleus relative to the level in the cytoplasm correlated with a shorter survival time.
"This is a new potential biomarker for predicting survival in patients with colorectal cancer," says Mark Gustavson, lead author of the study and a postdoctoral fellow in the Department of Pathology.
He says this is the first study to show that the relationship between nuclear and cytoplasmic levels of TS can predict survival, although TS levels have been used as a marker for decreased survival and response to therapy.
The results were presented in September in Chicago at the first meeting on Molecular Diagnostics in Cancer Therapeutic Development, which was organized by the American Association for Cancer Research.
Gustavson and his colleagues determined subcellular TS levels using AQUA™, a system developed at Yale and licensed to HistoRx that combines fluorescence-based imaging, microscopy and high-throughput tissue microarray technologies to determine subcellular TS levels.
Looking at tissue samples from 518 colorectal cancer patients diagnosed between 1970 and 1981, the researchers found that just 51% of patients with high TS levels in the nucleus survived for five years compared to 71% of those with lower levels. TS levels in the cytoplasm were also higher in patients with shorter survival times, though they were not as strong a predictor of survival as TS levels in the nucleus.
The researchers next looked at the ratio between TS levels in the nucleus and in the cytoplasm and discovered that a high ratio predicted decreased survival. Moreover, the cytoplasmic-to-nuclear ratio appeared to be an independent marker, not correlated with high nuclear levels. Among patients with a high ratio, more than half, 55%, did not have high nuclear levels.
-- By Jacqueline Weaver
T H I S
W E E K ' SS T O R I E S
Medical School receives $57.3 million NIH grant
Medical School receives $11.5 million to improve cancer diagnosis . . .
Museum technicians to show their own artworks at Open Studios
Student designs creative alternative to traditional construction fencing
MORE SCHOOL OF MEDICINE NEWS
Grant supports work predicting outcomes in cancer patients
High testosterone kills nerve cells, says study
Team learns why leptin has powerful effect on appetite
New biomarker predicts survival in colorectal cancer
Proteins shown to have surprising effects on autoimmune disease
Relationship between stress and disease to be explored
Conference looks at literature's power to ease children's fears
Study: Myo1f has key role in mobilizing immune system
Study explores cost-effectiveness of using prizes in drug therapy
Heart studies often don't include kidney patients at high riskLevin, Zedillo discuss the role of UNESCO at Paris event
'Women and Globalization' will be the topic of discussion . . .
Marketing executives and scholars to discuss latest trends
Australia's history and people are focus of film
Exhibit features paintings of England by Venetian artist 'Canaletto'
Lecture will examine the U.N. and 21st-century challenges
Lab talk
Play reading and talk will explore the romantic life of Benjamin Franklin
Tanner Lectures and related discussion to focus on humanities
'Crafting a Life' is the theme of this year's Law School reunions
Student research on early French songs culminates in . . .
Mutual interests
ALL gallery after-party celebrates artists in its newest exhibit and in CWOS
Campus Notes
Yale Books in Brief
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home